Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Regeneron Maintains Its Momentum During Pandemic

May 05 2020

• By Jessica Merrill

Regeneron reported a solid first quarter • Source: Shutterstock

Related Content

Sanofi/Regeneron Refocus Kevzara COVID-19 Trial On Critical Patients, Showing Value Of A Proper Trial

Apr 27 2020

Sanofi/Regeneron Ready To Forge Ahead With Libtayo Filings In NSCLC

Apr 27 2020

Sanofi's Libtayo Succeeds In Basal Cell Carcinoma Study

May 05 2020

After Remdesivir's Emergency Use Authorization, US Gov't Must Now Decide How To Distribute Limited Supply

May 02 2020

Regeneron Wades Deeper Into Oncology With Ambitions To Be A Force In The Space

Feb 06 2020

Novartis’s Beovu Launch Clouded By Safety Worries

Feb 25 2020

Related Companies

Regeneron Pharmaceuticals, Inc.

Sanofi

Gilead Sciences, Inc.

Novartis AG

Additional Topics

Sales & Earnings Coronavirus COVID-19 Business Strategies Commercial

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window